258 related articles for article (PubMed ID: 15691886)
1. Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis.
Beattie J; Phillips K; Shand JH; Szymanowska M; Flint DJ; Allan GJ
J Mol Endocrinol; 2005 Feb; 34(1):163-75. PubMed ID: 15691886
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
3. Zinc partitions insulin-like growth factors (IGFs) from soluble IGF binding protein (IGFBP)-5 to the cell surface receptors of BC3H-1 muscle cells.
McCusker RH; Novakofski J
J Cell Physiol; 2003 Dec; 197(3):388-99. PubMed ID: 14566968
[TBL] [Abstract][Full Text] [Related]
4. The IGF system in the neonatal ovine uterus.
Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
[TBL] [Abstract][Full Text] [Related]
5. IGFBP-3 and IGFBP-5 associate with the cell binding domain (CBD) of fibronectin.
Beattie J; Kreiner M; Allan GJ; Flint DJ; Domingues D; van der Walle CF
Biochem Biophys Res Commun; 2009 Apr; 381(4):572-6. PubMed ID: 19236847
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs.
Chandrashekaran IR; Yao S; Wang CC; Bansal PS; Alewood PF; Forbes BE; Wallace JC; Bach LA; Norton RS
Biochemistry; 2007 Mar; 46(11):3065-74. PubMed ID: 17305365
[TBL] [Abstract][Full Text] [Related]
7. Multivalent cations depress ligand affinity of insulin-like growth factor-binding proteins-3 and -5 on human GM-10 fibroblast cell surfaces.
Sackett RL; McCusker RH
J Cell Biochem; 1998 Jun; 69(3):364-75. PubMed ID: 9581874
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment.
Forsten KE; Akers RM; San Antonio JD
J Cell Physiol; 2001 Dec; 189(3):356-65. PubMed ID: 11748593
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding proteins-3 and -5 form sodium dodecyl sulfate-stable multimers.
Koedam JA; Hoogerbrugge CM; Van Buul-Offers SC
Biochem Biophys Res Commun; 1997 Nov; 240(3):707-14. PubMed ID: 9398631
[TBL] [Abstract][Full Text] [Related]
10. A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit.
Twigg SM; Hardman KV; Baxter RC
Growth Horm IGF Res; 2000 Aug; 10(4):215-23. PubMed ID: 11032705
[TBL] [Abstract][Full Text] [Related]
11. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
13. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
[TBL] [Abstract][Full Text] [Related]
14. Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.
Devi GR; Graham DL; Oh Y; Rosenfeld RG
Growth Horm IGF Res; 2001 Aug; 11(4):231-9. PubMed ID: 11735239
[TBL] [Abstract][Full Text] [Related]
15. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.
Foulstone EJ; Savage PB; Crown AL; Holly JM; Stewart CE
J Cell Physiol; 2003 Apr; 195(1):70-9. PubMed ID: 12599210
[TBL] [Abstract][Full Text] [Related]
16. The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis.
Durham SK; Suwanichkul A; Hayes JD; Herington AC; Powell DR; Campbell PG
Horm Metab Res; 1999; 31(2-3):216-25. PubMed ID: 10226805
[TBL] [Abstract][Full Text] [Related]
17. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding proteins initiate cell death and extracellular matrix remodeling in the mammary gland.
Flint DJ; Boutinaud M; Tonner E; Wilde CJ; Hurley W; Accorsi PA; Kolb AF; Whitelaw CB; Beattie J; Allan GJ
Domest Anim Endocrinol; 2005 Aug; 29(2):274-82. PubMed ID: 15998501
[TBL] [Abstract][Full Text] [Related]
19. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor system modulates retinal pigment epithelial cell tractional force generation.
Mukherjee S; Guidry C
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1892-9. PubMed ID: 17389525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
